A comprehensive view of pfizer inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer Submits Patent Application for Capsule with Reduced Powder Leakage
Published: March 20, 2023 by Chemical Patent News
Pfizer and Astellas report Phase 3 study shows Xtandi enzalutamide plus leuprolide significantly improves metastasis-free survival in men with non-metastatic prostate cancer
Published: March 17, 2023 by Contify Life Science News
Fitch revises Pfizer's outlook to stable from positive on proposed US$43B acquisition of Seagen; deal viewed as strategically constructive and will boost Pfizer's oncology presence, but transaction could stress EBITDA leverage in intermediate term
Published: March 16, 2023 by ENP Newswire
Pfizer recalls 4.2 million units of prescription Nurtec ODT 75 mg orally disintegrating migraine therapy tablets sold in cartons containing one blister card of 8 tablets; drug package does not meet child-resistant packaging requirements
Published: March 16, 2023 by CE Noticias Financieras
Pfizer is working on a new child-proof packaging for its migraine drug, Nurtec ODT, after safety concerns led to a recall alert from the US Consumer Product Safety Commission
Published: March 16, 2023 by Reuters

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count